ClinicalTrials.gov
public full text
Public Domain
Clinical Translation of 18F-Labeled Hydroxyphenethylguanidines
The purpose of this study is to perform first-in-human PET imaging studies of two new cardiac sympathetic nerve imaging agents, 4-\[18F\]fluoro-meta-hydroxyphenethylguanidine (\[18F\]4F-MHPG) and 3-\[18F\]fluoro-para-hydroxyphenethylguanidine (\[18F\]3F-PHPG).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Value of 18F-FCH PET in Localizing Parathyroid Lesions: Comparison With MIBI Scan.#903522
- 18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection#1032162
- Creation of a Probabilistic Atlas of Normal Cerebral Uptake of 18F-FDG in PET/MRI.#873396
- EC17 for Intraoperative Imaging for Parathyroidectomy#812540
- Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm#804423
Record · ID 882417
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive